MKI67 and hepatocellular carcinoma: However, Schmitz et al.27 reported that the proliferative capacity of AKR1B10-positive hepatocellular carcinoma and its Ki-67 expression rate were significantly lower than those of AKR1B10-negative hepatocellular carcinoma.